24.34
0.16%
-0.04
Dopo l'orario di chiusura:
24.34
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALKS Giù?
Forum
Previsione
Frazionamento azionario
Alkermes plc Borsa (ALKS) Ultime notizie
Do Options Traders Know Something About Alkermes (ALKS) Stock We Don't? - Yahoo Finance
Yahoo Finance
Alkermes plc (NASDAQ:ALKS) Shares Sold by Massachusetts Financial Services Co. MA - Defense World
Defense World
Principal Financial Group Inc. Acquires 864,389 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
MarketBeat
Alkermes (ALKS) Stock Up 15% in Six Months: Here's Why - Yahoo Movies Canada
Yahoo Movies Canada
Principal Financial Group Inc. Purchases 864389 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
Alkermes plc (NASDAQ:ALKS) Position Decreased by BNP Paribas Financial Markets - MarketBeat
MarketBeat
Alkermes plc (NASDAQ:ALKS) Stock Holdings Lowered by BNP Paribas Financial Markets - Defense World
Defense World
(ALKS) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Stock Traders Daily
Victory Capital Management Inc. Purchases 675 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
Charles Schwab Investment Management Inc. Has $59.56 Million Stock Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
Natixis Advisors L.P. Has $1.02 Million Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
The Bottom Fishing Club: Alkermes Has Great Value And Safety (NASDAQ:ALKS) - Seeking Alpha
Seeking Alpha
Biotech Stock Roundup: ICPT Strong on NASH Drug Data, Collaborations & More - Yahoo New Zealand News
Yahoo New Zealand News
Russell Investments Group Ltd. Sells 81,673 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
MarketBeat
Biogen's (BIIB) Oral MS Drug Vumerity Gets Approval in Europe - Yahoo Singapore News
Yahoo Singapore News
Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences - PR Newswire
PR Newswire
Swiss National Bank Trims Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
Alkermes plc (NASDAQ:ALKS) Shares Sold by Russell Investments Group Ltd. - Defense World
Defense World
Teacher Retirement System of Texas Has $12.55 Million Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
MarketBeat
Multiple insiders bought Alkermes plc (NASDAQ:ALKS) stock earlier this year, a positive sign for shareholders - Yahoo Movies Canada
Yahoo Movies Canada
Alkermes (ALKS) Beats on Q2 Earnings & Sales, Ups '21 View - Yahoo Singapore News
Yahoo Singapore News
Should You Buy Alkermes (ALKS) Ahead of Earnings? - Yahoo Movies Canada
Yahoo Movies Canada
Are Medical Stocks Lagging Alkermes (ALKS) This Year? - Yahoo Canada Shine On
Yahoo Canada Shine On
Alkermes plc (NASDAQ:ALKS) Shares Purchased by Los Angeles Capital Management LLC - Defense World
Defense World
Sale of Alkermes facility in Athlone is completed - Westmeath Independent
Westmeath Independent
117,000 Shares in Alkermes plc (NASDAQ:ALKS) Purchased by LSV Asset Management - MarketBeat
MarketBeat
Fisher Asset Management LLC Buys 572 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
Cwm LLC Has $55000 Stake in Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
(ALKS) Technical Pivots with Risk Controls - Stock Traders Daily
Stock Traders Daily
Alkermes (ALKS) to Report Q4 Earnings: What's in Store? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Alkermes' (NASDAQ:ALKS) Solid Profits Have Weak Fundamentals - Simply Wall St
Simply Wall St
Alkermes' (ALKS) Schizophrenia, Bipolar I Disorder Drug Approved - Yahoo New Zealand News
Yahoo New Zealand News
Alkermes' (ALKS) Schizophrenia, Bipolar I Disorder Drug Approved - Yahoo New Zealand News
Yahoo New Zealand News
Are Medical Stocks Lagging Alkermes (ALKS) This Year? - Yahoo Singapore News
Yahoo Singapore News
BioCryst (BCRX) Wins Japanese Approval for HAE Drug Orladeyo - Yahoo Singapore News
Yahoo Singapore News
Alkermes (ALKS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo New Zealand News
Yahoo New Zealand News
Compared to Estimates, Alkermes (ALKS) Q2 Earnings: A Look at Key Metrics - Yahoo Canada Shine On
Yahoo Canada Shine On
New York State Common Retirement Fund Buys 11747 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
Alkermes plc (NASDAQ:ALKS) Expected to Post Q1 2025 Earnings of $0.43 Per Share - Defense World
Defense World
Brokers Offer Predictions for Alkermes plc's Q1 2025 Earnings (NASDAQ:ALKS) - MarketBeat
MarketBeat
Alkermes plc (NASDAQ:ALKS) Expected to Post Q1 2025 Earnings of $0.43 Per Share - Defense World
Defense World
GAMMA Investing LLC Takes Position in Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
Alkermes (NASDAQ:ALKS) Stock Rating Reaffirmed by HC Wainwright - Defense World
Defense World
Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 49% Undervaluation? - Yahoo Movies Canada
Yahoo Movies Canada
Alkermes Advances Narcolepsy Drug Studies - Sleep Review
Sleep Review
Alkermes Advances Narcolepsy Drug Studies - Sleep Review
Sleep Review
Alkermes (ALKS) Grants Teva License to Market Generic Drug - Yahoo Lifestyle UK
Yahoo Lifestyle UK
7 Analysts Assess Alkermes: What You Need To Know
Benzinga
Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks Investment Research
Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates - Zacks Investment Research
Zacks Investment Research
Capitalizzazione:
|
Volume (24 ore):